Estrapronicate
Estrapronicate (INN), also known as estradiol nicotinate propionate is an estrogen medication and estrogen ester which was never marketed.[1] It was studied as a component of the experimental tristeroid combination drug Trophobolene, which contained nandrolone decanoate, estrapronicate, and hydroxyprogesterone heptanoate.[2][3]
 | |
| Clinical data | |
|---|---|
| Other names | Estradiol propionicotinate; Estradiol propionate nicotinate; Estradiol nicotinate propionate; Estradiol 17β-nicotinate 3-propionate |
| Routes of administration | Intramuscular injection |
| Drug class | Estrogen; Estrogen ester |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.021.786  |
| Chemical and physical data | |
| Formula | C27H31NO4 |
| Molar mass | 433.548 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
See also
References
- Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 898–. ISBN 978-1-4757-2085-3.
- Excerpta medica. Section 8, Neurology and neurosurgery. 1981. p. 10.
- Testosterone Congeners—Advances in Research and Application: 2013 Edition: ScholarlyBrief. ScholarlyEditions. 21 June 2013. pp. 137–. ISBN 978-1-4816-9288-5.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.